Ineffective IFN-mediated innate immunity, due to neutralizing autoantibodies to type I IFNs and genetic polymorphisms causing a reduced expression of type I IFN receptor or inducible genes, has been strongly associated with inability to control the primary SARS-CoV-2 infection and a high risk of fatal COVID-19. The gene discussed is IFNA1; the disease is COVID-19.